Drug that prevents hot flushes to be available on NHS in England
#drug #hot flushes #NHS #England #treatment #menopause #healthcare access
📌 Key Takeaways
- A drug preventing hot flushes will be available on the NHS in England.
- This expands treatment options for individuals experiencing hot flushes.
- The availability aims to improve access to effective symptom management.
- It reflects NHS efforts to address menopausal or related health issues.
📖 Full Retelling
<p>Veoza, also known as fezolinetant, will be offered to women for whom HRT is unsuitable</p><p>More than 500,000 women in England are to be offered a drug on the NHS that prevents hot flushes.</p><p>The green light for Veoza, also known as fezolinetant, comes after the medicines watchdog, the National Institute for Health and Care Excellence, authorised it for use on Wednesday.</p> <a href="https://www.theguardian.com/society/2026/mar/11/drug-that-prevents
🏷️ Themes
Healthcare, Medication Access
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
<p>Veoza, also known as fezolinetant, will be offered to women for whom HRT is unsuitable</p><p>More than 500,000 women in England are to be offered a drug on the NHS that prevents hot flushes.</p><p>The green light for Veoza, also known as fezolinetant, comes after the medicines watchdog, the National Institute for Health and Care Excellence, authorised it for use on Wednesday.</p> <a href="https://www.theguardian.com/society/2026/mar/11/drug-that-prevents
Read full article at source